Investigation of annexin A5 as a biomarker for Alzheimer's disease using neuronal cell culture and mouse model

Alzheimer's disease (AD) differs from other forms of dementia in its relation to amyloid β peptide (Aβ). Aβ, a proteolytic product of amyloid precursor proteins (APP), has a toxic effect on neuronal cells, which involves perturbation of their Ca2+ homeostasis. This effect implies that changes o...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroscience research Vol. 88; no. 12; pp. 2682 - 2692
Main Authors Yamaguchi, Mami, Kokai, Yasuo, Imai, Shin-Ichi, Utsumi, Kumiko, Matsumoto, Kyoichi, Honda, Hirohito, Mizue, Yuka, Momma, Masako, Maeda, Tetsu, Toyomasu, Shozo, Ito, Yoichi M., Kobayashi, Seijyu, Hashimoto, Eri, Saito, Toshikazu, Sohma, Hitoshi
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer's disease (AD) differs from other forms of dementia in its relation to amyloid β peptide (Aβ). Aβ, a proteolytic product of amyloid precursor proteins (APP), has a toxic effect on neuronal cells, which involves perturbation of their Ca2+ homeostasis. This effect implies that changes of protein expression in neuronal cells with calcium stress should provide a molecular marker for this disease. In the present study, we used the supernatant from a neuronal cell culture after incubation with or without Aβ and isolated a Ca2+‐dependent acidic phospholipid binding fraction to perform a proteomic study. Several unique proteins were identified after incubation with Aβ. We focused on annexin A5, among these proteins, because it binds both Ca2+ and lipids likely to be involved in calcium homeostasis. Tg2576 transgenic mice (AD model) overexpressing mutant human APP showed a significant increase of annexin A5 in the brain cortex but not in other organs, including liver, kidney, lung, and intestine. In human plasma samples, the level of annexin A5 was significantly increased in a proportion of AD patients compared with a control group (P < 0.0001 in the logistic regression analysis). From the receiver operating characteristic (ROC) curve with plasma annexin A5 concentrations, the mean area under the curve (AUC 0.898) suggests that annexin A5 is a favorable marker for AD. © 2010 Wiley‐Liss, Inc.
Bibliography:ArticleID:JNR22427
Program for developing the supporting system for upgrading the education and research from the Ministry of Health, Labor and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science and Technology of Japan - No. 21591489
istex:A301B1F1999890D098949D6FF02D18008CF5C7BE
ark:/67375/WNG-Q65M5XWJ-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0360-4012
1097-4547
1097-4547
DOI:10.1002/jnr.22427